Evidence suggests that expression of the MDR1 gene in human tumors is associated with malignancy in a tissue-dependent fashion (pages 447–450).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gottesman, M.M. & Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385–427 (1993).
Chabner, B.A. & Fojo, A. Multidrug resistance: P-glycoprotein and its allies —; the elusive foes. J. Natl. Cancer Inst. 81, 910–913 (1989).
Bargou, R.C. et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nature Med. 4, 447–450 (1997).
Cordon-Cardo, C. et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38, 1277–1287 (1990).
van Kalken, C.K. et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am. J. Pathol. 141, 1063–1072 (1992).
Baldini, N. et al. Nuclear immunolocalization of P-glycoprotein in multidrug resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur. J. Cell Biol. 68, 226–239 (1995).
Valverde, M.A. et al. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355, 830–833 (1992).
Abrahams, E.H. et al. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA 90, 312–316 (1993).
Goldstein, L.J. et al. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81, 116–124 (1989).
Biedler, J.L. & Spengler, B.A. Reverse transformation of multidrug-resistant Cells. Cancer Metastasis Rev. 13, 191–207 (1994).
Bradley, G. & Ling, V., P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev. 13, 223–233 (1994).
Linn, S.C. et al. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br. J. Cancer 74, 63–68 (1996).
Chin, K.-V., Ueda, K., Pastan, I. & Gottesman, M.M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255, 459–462 (1992).
Kohno, K. et al. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J. Biol. Chem. 269, 20503–20508 (1994).
Goldsmith, M.E., Madden, M.J., Morrow, C.S. & Cowan, K.H. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (MDR1) gene. J. Biol. Chem. 268, 5856–5860 (1993).
Wolffe, A.P. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. BioEssays 16, 245–251 (1994).
Ladomery, M. & Sommerville, J. A role for Y-box proteins in cell proliferation. BioEssays 17, 9–11 (1995).
Scotlandi, K. et al. Multidrug resistance and malignancy in human osteosarcoma. Cancer Res. 56, 2434–2439 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baldini, N. Multidrug resistance — a multiplex phenomenon. Nat Med 3, 378–380 (1997). https://doi.org/10.1038/nm0497-378
Issue Date:
DOI: https://doi.org/10.1038/nm0497-378
This article is cited by
-
Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas
Apoptosis (2007)
-
Drug resistance in brain diseases and the role of drug efflux transporters
Nature Reviews Neuroscience (2005)
-
Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation
Oncogene (2003)
-
Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells
Oncogene (2002)
-
Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance
Oncogene (2001)